BiochemProbe — Life Science Research Reagents

CZC-54252 free base · Synonyms: CZC 54252 · CZC54252

CZC-54252 is a potent and selective LRRK2 inhibitor.

For research use only. Not for human or veterinary use.

Target LRRK2
Research area Neurological Disease
Purity >98% Stock Inquire

CZC-54252 structure

CAS No.: 1191911-27-9

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
500 mg USD 698.00 BP-02511-500mg In stock Get quote
1 g USD 1,298.00 BP-02511-1g In stock Get quote
2 g USD 2,098.00 BP-02511-2g In stock Get quote
5 g Inquire BP-02511-5g In stock Inquire

Need another size or custom synthesis? Request a quote.

Description

CZC-54252 is a potent and selective LRRK2 inhibitor with IC50s of 1.28 nM and 1.85 nM for wild-type and G2019S LRRK2, respectively. CZC-54252 attenuates G2019S LRRK2-induced human neuronal injury with an EC50 of ~1 nM. CZC-54252 has a neuroprotective activity .

Biological activity

CZC-54252 is a potent and selective LRRK2 inhibitor with IC50s of 1.28 nM and 1.85 nM for human wild type LRRK2 and G2019S LRRK2, respectively.

Identifiers

SMILES
COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2NS(C)(=O)=O)=N1)N1CCOCC1
InChIKey
CLGWUCNXOBLWFM-UHFFFAOYSA-N

Specifications

MW (average)
504.9900
Formula
C22H25ClN6O4S
CAS No.
1191911-27-9
Physical state
Solid
Color
White to off-white
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20°C 3 years; 4°C 2 years. In solvent -20°C 1 year

Solubility

Soluble in DMSO

In vitro
DMSO : ≥ 100 mg/mL

References

[1].Ramsden N, et al. Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons. ACS Chem Biol. 2011 Oct 21;6(10):1021-8.

Same target

Search LRRK2

Same research area

Search Neurological Disease